共 50 条
- [22] Vedolizumab trough concentrations are associated with endoscopic response in patients with inflammatory bowel disease [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S367 - S368
- [24] Post induction infliximab trough levels predict long-term endoscopic remission in paediatric patients with inflammatory bowel disease [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S362 - S363
- [25] Endoscopic and Histologic Response and Remission in Inflammatory Bowel Disease Patients Initiating Vedolizumab [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S783 - S784
- [26] Clinical response of vedolizumab at week 6 predicted endoscopic remission at week 24 in ulcerative colitis [J]. JGH OPEN, 2021, 5 (09): : 1056 - 1062
- [30] Role of vedolizumab trough levels in predicting clinical response in Inflammatory Bowel Disease: a multicentre prospective study [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1216 - I1216